These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 14679781

  • 1. [Perospirone therapy in elderly patients with schizophrenia].
    Masui T, Honma H, Kondo C, Osawa T, Iwasaki S, Matsubara S.
    Seishin Shinkeigaku Zasshi; 2003; 105(10):1247-53. PubMed ID: 14679781
    [Abstract] [Full Text] [Related]

  • 2. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
    Okugawa G, Kato M, Wakeno M, Koh J, Morikawa M, Matsumoto N, Shinosaki K, Yoneda H, Kishimoto T, Kinoshita T.
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
    [Abstract] [Full Text] [Related]

  • 3. Perospirone in the treatment of patients with delirium.
    Takeuchi T, Furuta K, Hirasawa T, Masaki H, Yukizane T, Atsuta H, Nishikawa T.
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):67-70. PubMed ID: 17239041
    [Abstract] [Full Text] [Related]

  • 4. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
    Araki T, Yamasue H, Sumiyoshi T, Kuwabara H, Suga M, Iwanami A, Kato N, Kasai K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
    [Abstract] [Full Text] [Related]

  • 5. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006 Mar; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adverse effects of risperidone and haloperidol treatment in schizophrenia.
    Yen YC, Lung FW, Chong MY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical evaluation of risperidone in Asian patients with schizophrenia in Singapore.
    Chong SA, Yap HL, Low BL, Choo CH, Chan AO, Wong KE, Mahendran R, Chee KT.
    Singapore Med J; 1999 Jan; 40(1):41-3. PubMed ID: 10361485
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
    Kishi T, Iwata N.
    CNS Drugs; 2013 Sep; 27(9):731-41. PubMed ID: 23812802
    [Abstract] [Full Text] [Related]

  • 11. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
    Nakamura M, Ogasa M, Guarino J, Phillips D, Severs J, Cucchiaro J, Loebel A.
    J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA, Bossie CA, Zhu Y, Gharabawi G, Eerdekens M, Davidson M.
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term perospirone treatment with a single dose at bedtime in schizophrenia: relevant to intermittent dopamine D2 receptor antagonism.
    Kusumi I, Masui T, Koyama T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):520-2. PubMed ID: 18006133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.